KRAS and lung cancer: Basic experimental analysis revealed that lung cancer cell lines harboring KRAS G12C or KRAS G12V mutations exhibited increased Ras-related protein (RAL) A/B signaling but decreased PI3K/Akt signaling compared with other KRAS mutant isoforms or WT cell lines (43).